Clinical Trial

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

Study acronym: OTTODC19
Recruiting
View on ClinicalTrials.gov →
Summary
Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors). A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-09 -> 2027-09 2026-08-01
minor Completion pushed: 2025-09 -> 2027-09 2026-08-01
Trial Details
NCT Number NCT05384561
Lead Sponsor Université du Québec à Trois-Rivières
Conditions Hyposmia, COVID-19, Parosmia, Anosmia, SARS-CoV-2 Infection
Enrollment 70 participants
Start Date 2022-05-31
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-31